-
Retro Fitness Sprints Up Entrepreneur’s Franchise 500 List to No. 119
Post on 1/15/17
-
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part V
Post on 1/26/17
-
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part IV
Post on 1/25/17
-
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part III
Post on 1/23/17
-
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part II
Post on 1/19/17
-
A Video Conversation with Dean Petkanas, CEO of Kannalife Sciences - Part I
Post on 1/17/17
-
Vertex And German Merck Find Their Perfect Fit
Post on 1/13/17
-
Merck Muscles Into Bristol's Combo Space
Post on 1/12/17
-
Why Novartis Dropped 15.1% in 2016
Post on 1/12/17
-
Celgene Is On Its Way To $196
Post on 1/12/17
-
3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
Post on 1/12/17
-
AmerisourceBergen (ABC) Presents At J.P. Morgan Healthcare Conference
Post on 1/12/17
-
Johnson & Johnson: Should It Be In Your 2017 Dividend Portfolio?
Post on 1/12/17
-
Johnson & Johnson: Too Big To Break Up
Post on 1/11/17
-
Can Johnson & Johnson Upset Chevron In The Divisional Round?
Post on 1/11/17
-
Johnson & Johnson Stock Split: Coming in 2017?
Post on 1/11/17
-
1 Perfect Stock to Invest in the Pharmaceutical Industry
Post on 1/11/17
-
What's Next For Celgene
Post on 1/11/17
-
Why Celldex Therapeutics Imploded in 2016
Post on 1/10/17
-
2 Reasons Pfizer's Stock Beat the Field in 2016
Post on 1/10/17
-
Is Celgene Simply the Best Biotech Stock on the Planet?
Post on 1/10/17
-
Akers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants
Post on 1/10/17
-
Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases
Post on 1/9/17
-
Advaxis Provides 2017 Business Outlook
Post on 1/9/17
-
Johnson & Johnson Medical Devices Companies Launch CareAdvantage
Post on 1/9/17
Philadelphia
